AxanLab

A simple guide to how mitochondria work. 4️⃣ primar jobs Mitochondria are more than the “powerhouse of the cell.” They’re multitasking organelles that control energy, stress, genetics, and even cell survival. Here are the 4 primary jobs they do: 1️⃣ ATP Generation (Energy Production) Mitochondria convert glucose, fats, and amino acids into acetyl-CoA, which enters the TCA cycle and electron transport chain (ETC). The result: ATP, the energy currency for everything from nerve signals to muscle contractions. 🟢 Example: Every time you move or think, mitochondria are fueling the process. 2️⃣ ROS Balance - i.e., redox control As mitochondria make ATP, they also generate reactive oxygen species (ROS) damaging byproducts. Antioxidant enzymes (like catalase, SOD, glutathione peroxidase) keep ROS under control. Too much ROS = oxidative stress → cell injury or death. 🟢 Example: Exercise trains mitochondria to better balance ROS, which is one reason it’s so protective. 3️⃣ mtDNA Maintenance (genetic stability) Mitochondria have their own DNA (mtDNA), which encodes key ETC proteins. Damage or mutations in mtDNA reduce energy output and contribute to diseases. mtDNA mutations accumulate with age, linking mitochondria to neurodegeneration and aging. 🟢 Example: Mitochondrial DNA damage is a hallmark in Alzheimer’s and Parkinson’s disease. 4️⃣ Membrane Dynamics (fission & fusion) Mitochondria constantly split (fission) and merge (fusion) to adapt to stress and demand. This dynamic reshaping controls quality, removing damaged mitochondria (mitophagy) and keeping networks healthy. 🟢 Example: Impaired fission/fusion is seen in metabolic disorders and neurodegenerative disease. Mitochondria don’t just make energy. They balance oxidative stress, protect genetic integrity, and constantly remodel themselves to keep cells alive. Supporting mitochondrial health means supporting the foundation of cellular life.

Hereditary Alzheimer's Transmitted Via Bone Marrow Transplants Alzheimer's disease, traditionally seen as a brain-centric condition, may have systemic origins and can be accelerated through bone marrow transplants from donors with familial Alzheimer's to healthy mice. This study underscores the disease's potential transmission via cellular therapies and suggests screening donors for Alzheimer's markers to prevent inadvertent disease transfer. By demonstrating that amyloid proteins from peripheral sources can induce Alzheimer's in the central nervous system, this research shifts the understanding of Alzheimer's towards a more systemic perspective, highlighting the need for cautious screening in transplants and blood transfusions. 1/2

Entry 3: Need an extra pair of thumbs?